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Abstract
Background: In children born prematurely and those surviving cerebral ischemia there are white matter abnormalities that
correlate with neurological dysfunction. Since this injury occurs in the immature brain, when the majority of subventricular
zone (SVZ) cells generate white matter oligodendrocytes, we sought to study the effect this injury has on gliogenesis from
the SVZ. We hypothesized that there is aberrant glial cell generation from the SVZ after neonatal hypoxia ischemia (H/I) that
contributes to an increased astrogliogenesis with concomitant oligodendroglial insufficiency. Mechanistically we
hypothesized that an increase in specific locally produced cytokines during recovery from injury were modifying the
differentiation of glial progenitors towards astrocytes at the expense of the more developmentally-appropriate
oligodendrocytes.
Methodology/Principal Finding: For these studies we used the Vannucci H/I rat model where P6 rats are subjected to
unilateral common carotid ligation followed by 75 min of systemic hypoxia. Retroviral lineage tracing studies combined
with morphological and immunohistochemical analyses revealed the preferential generation of SVZ-derived white matter
astrocytes instead of oligodendrocytes post hypoxia/ischemia. Microarray and QRT-PCR analyses of the damaged SVZ
showed increased expression of several cytokines and receptors that are known to promote astrocyte differentiation, such
as EGF, LIF and TGFß signaling components. Using gliospheres to model the neonatal SVZ, we evaluated the effects of these
cytokines on signal transduction pathways regulating astrocyte generation, proliferation and differentiation. These studies
demonstrated that combinations of EGF, LIF and TGFß1 reconstituted the increased astrogliogenesis. TGFß1-induced Smad
2/3 phosphorylation and the combination of EGF, LIF and TGFß1 synergistically increased STAT3 phosphorylation over
single or double cytokine combinations. Pharmacologically inhibiting ALK5 signaling in vitro antagonized the TGFß1-
induced increase in astrocyte generation and antagonizing ALK5 signaling in vivo similarly inhibited astrogliogenesis within
the SVZ during recovery from H/I.
Conclusion/Significance: Altogether, these data indicate that there is aberrant specification of glial precursors within the
neonatal SVZ during recovery from neonatal H/I that is a consequence of altered cytokine signaling. Our studies further
suggest that antagonizing the ALK5 receptor will restore the normal pattern of cell differentiation after injury to the
immature brain.
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Introduction
Neonatal hypoxia/ischemia (H/I) is a major cause of morbidity
resulting from complications during the birthing process that leads
to cognitive, sensory and motor deficits in approximately 25% of
affected infants. Accumulating evidence has demonstrated that
immature oligodendrocytes are extremely sensitive to hypoxia,
oxidative stress and glutamate, which are thought to contribute to
the focal cystic degeneration as well as to diffuse injury seen in the
periventricular white matter. Investigators are also beginning to
appreciate the impact of this injury on the SVZ, which is the
region of the immature brain that harbors multipotential neural
stem/progenitors, endowed with the ability to regenerate neurons,
astrocytes and oligodendrocytes. Using the classic Vannucci H/I
animal model [1,2,3,4], we have previously demonstrated that
neonatal white matter immature oligodendrocytes undergo acute
excitotoxic cell death as do progenitors in the SVZ following H/I,
while the stem cells are resilient to death effectors [5,6,7,8]. Not
PLoS ONE | www.plosone.org 1 March 2010 | Volume 5 | Issue 3 | e9567only are the stem cells resilient, but several studies have shown that
they expand subsequent to H/I and can regenerate neurons and
possibly some oligodendrocytes [9,10,11,12,13]. Since the stem
cells in the SVZ are resilient to H/I and in fact participate in CNS
regeneration, the failure of the white matter to regenerate is not
easily reconciled.
Studies characterizing the cells in the neonatal SVZ have
demonstrated that in addition to the tripotential stem/progenitors
there are more restricted bipotential glial progenitors (BGP) that
are capable of producing oligodendrocytes or astrocytes develop-
mentally [14,15,16,17,18,19]. The decision to produce one cell
type versus the other appears to be dictated by signals that the
progenitors receive from their local environment [20]. In the adult
brain, mature resting astrocytes can be induced to become
reactive, a process known as reactive gliosis, as a consequence of
cytokines produced by damaged neurons and reactive microglia.
Histopathologic studies on the brains of infants who have expired
after neonatal H/I have shown similar gliosis in affected regions
[21,22]. However, astrocyte generation in the neonatal brain is
incomplete at the time of injury, thus the reactive astrocytes in the
neonatal brain may have a different origin than those in the adult
brain. Accordingly, we hypothesized that the gliosis in the infant
brain and the failure of oligodendrocyte regeneration after
neonatal H/I may be linked and that the extrinsic signals that
determine sequential cell fate specification within the postnatal
SVZ during normal development are disturbed following H/I thus
shifting the production in the SVZ from oligodendrocytes to
astrocytes. This mis-specification will then contribute to the
permanent deficit in periventricular white matter oligodendrocytes
subsequent to H/I. The objective of this study was to test this
hypothesis and to identify the specific signals that coordinate the
differentiation of the glial progenitors of the SVZ.
Results
Aberrant Glial Specification from the SVZ after Neonatal
H/I
We evaluated gliogenesis subsequent to H/I using immunoflu-
orescence methods as well as by evaluating cell proliferation within
the SVZ and by fate mapping SVZ cells using replication deficient
retroviruses. Using the Rip antibody to visualize immature and
mature oligodendrocytes we observed significantly less myelin and
fewer oligodendrocytes in the ipsilateral hemisphere (ILH) (Fig. 1C)
compared to the contralateral hemisphere (CLH) at 7 days of
recovery (Fig. 1B). This decrease in myelin staining was
accompanied by a dramatic increase in the number of GFAP
positive cells (Fig. 1A). At 7 days of recovery, significant increases
in immature astrocytes were observed in the ILH, as assessed by
increased vimentin, S100b and GFAP staining (Fig. 1E,G)
compared to the CLH (Fig. 1D,F). Many of these astrocytes were
newly born cells, as there was an increase in stellate BrdU+/
Vimentin+ cells around the lateral ventricles at 7 days recovery
post H/I (Fig. 1H). These observations are consistent with the
hypothesis that H/I decreases the overall population of mature
myelinating oligodendrocytes and induces astrocyte production.
To determine whether there was a shift in glial specification in
the periventricular white matter from cells with origins in the SVZ,
we performed replication-deficient retrovirus fate-mapping. Ret-
roviruses were stereotactically injected bilaterally into the lateral
ventricles 2 days after neonatal H/I. These retroviruses label
mitotically active cells, including SVZ progenitors. Indeed at 2
days of recovery almost all of the retrovirally labeled cells were
located within the SVZ (Fig. S1C,D). By 12 days of recovery from
H/I, most of the infected cells had migrated out of the SVZ and
were mostly located in the white matter of the corpus callosum
(Fig. S1B). A morphological analysis of glial phenotypes revealed
almost a doubling in the percentage of astrocytes with a
concurrent 50% decrease in both the percentage of myelinating
oligodendrocytes and total oligodendrocytes (Fig. 2A, B; p,0.05).
We also used a GFP encoding retrovirus together with
immunofluorescence for astrocytic Glial Fibrillary Acidic Protein
(GFAP) and oligodendrocytic Glutathione-s-Transferase pi
(GSTp). For these studies, we used a lower titer of retrovirus
and used DAPI to identify individual cells prior to classifying them
as GFAP+, GSTp+, weakly GSTp+, or double negative
(indeterminate) (Fig. 3A,B). Cells were evaluated at 3 weeks after
injury to enable them to more fully mature. At this time point,
majority of labeled cells were in the white matter. Confirming the
data provided in Fig. 2, which were collected at 12 days after
injury, the percentage of GFAP+ astrocytes increased from 18% to
45%, with a concomitant decrease in the percentage of GSTp+
oligodendrocytes from almost 80% in the ILH to 30% in the CLH
(Fig. 3C, p,0.05). We also found an increase in the percentage of
indeterminate cell types in the ILH (increase from 3% to 24%,
p,0.05). Moreover, there was a small population cells with the
morphology of oligodendrocytes, that only weakly stained positive
for GSTp, and these cells also increased in the ILH compared to
the CLH.
Reproducibly, in both the DAP and pNIT retrovirus experi-
ments, there were significantly fewer labeled cells in the ILH (Fig.
S1) as compared to the CLH. To determine whether this was due
to fewer cells being infected 2 days after injury when the viruses
were injected, we injected 5 uL of pNIT 2 days after H/I and the
animals sacrificed 48 h later. pNIT labeled cells were predomi-
nantly located in the SVZ, however, some cells had migrated into
the subcortical white matter. Echoing the results from the 2 and 3
week survival time points, at this earlier time point we observed
that there were few infected cells in the ILH as compared to the
CLH (Fig. S1A,C,D).
Signals Known to Induce Astrocytic Differentiation Are
Elevated in the Ipsilateral SVZ 7 Days after Injury
We hypothesized that extrinsic factors were responsible for the
aberrant production of astrocytes from the SVZ after H/I.
Therefore, to establish which genes were aberrantly expressed we
performed a gene array analysis with QRT-PCR validation. We
microdissected the SVZ and compared the RNA profiles from
ILH to the CLH using a commercially available nylon array. A
total of 11 genes were changed at least 2 fold with very few genes
showing decreased expression at 7 days of recovery from H/I (data
not shown). Of the genes whose expression were elevated in the
ipsilateral SVZ after injury on an average by at least 2-fold in three
independent experiments, 3 families caught our attention that
have previously been implicated in astrocyte specification; EGF,
LIF and TGFß. QPCR revealed no change in EGF mRNA
expression at 7 days of recovery from H/I between ILH and CLH
[23]. However, consistent with the array results, there was a 2-fold
increase in LIF and a 4-fold increase in TGFß1 (Table 1). While
there was no change in the expression of LIFR, the expression of
gp130 and EGFR were elevated by 1.5- and 1.44-fold,
respectively. The mRNA levels for the TGFb1 receptor, ALK1
was decreased by 0.6-fold, whereas levels for the ALK5 receptor
increased 1.8-fold. Other growth factors, including Notch, FGF
and BMP family members and their corresponding receptors, as
well as the cell surface glycoprotein CD44 were also increased on
the SuperArray, however, changes in their expression levels
remain to be validated (Table S1).
Neonatal Astroglial Dysgenesis
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from Gliospheres
Results from the SuperArray and QT-PCR indicated that there
were increases in astrogliogenic cytokines or their receptors in the
injured SVZ. To determine whether EGF, LIF and TGFß1 either
alone or in combination could promote astrocyte generation, we
tested their effects using an in vitro model for the glial progenitors of
the neonatal SVZ; gliospheres. Gliospheres were treated with
physiologically relevant concentrations of EGF, LIF and TGFß1
either alone or in combination and Western blots were performed
Figure 1. Over-production of astrocytes in the injured hemisphere at 7 days of recovery as a consequence of neonatal H/I. (A)
Sections from animals sacrificed at 7 days of recovery were stained with antibodies against GFAP (green) and counterstained with DAPI (blue). (B,C)
Sections were stained with Rip for oligodendrocytes and myelin in the ILH (C) compared to the CLH (B). (D,E) Sections were stained with antibodies
against GFAP (red), S100b (green) and counterstained with DAPI (blue) (E) depicts the ILH; (D) depicts the CLH (D). (F,G) The ILH SVZ (G) was stained
with antibodies against vimentin (green); (F) depicts the CLH. (H) Inset depicts BrdU+/Vim+ cells in the ILH SVZ from animals injected with BrdU (red)
at day 3 of recovery and analyzed at 7 days of recovery. Scale bar represents 100 mm (A), 50 mm (B,C,F,G), 25 mm (D,E,H).
doi:10.1371/journal.pone.0009567.g001
Neonatal Astroglial Dysgenesis
PLoS ONE | www.plosone.org 3 March 2010 | Volume 5 | Issue 3 | e9567Figure 2. SVZ cells preferentially generate white matter astrocytes rather than oligodendrocytes after H/I. Replication-incompetent
retroviruses containing the alkaline phosphatase (DAP) reporter gene were stereotactically injected at P8 into the lateral ventricles (two days after H/I).
For quantitative analysis at 10 days after DAP injection (A) cell types within the white matter (WM) were classified based upon morphological criteriaa s
either astrocytes (arrow), oligodendrocytes (arrowhead) or indeterminate (B). Data are averaged from 8 hypoxic sham, 8 contralateral hemispheres (CL),
and7 ipsilateral hemispheres(IL) * indicates p,0.05 comparedto CLH, ^ indicatesp,0.05comparedtohypoxicshamanimals as determined byANOVA
with Fisher’s PLSD post-hoc test.
doi:10.1371/journal.pone.0009567.g002
Figure 3. SVZ cells preferentially generate GFAP+ astrocytes in white matter instead of GST p + oligodendrocytes. Two mL of pNIT
replication-incompetent retroviruses containing the GFP reporter gene were stereotactically injected at P8 into the lateral ventricles (two days after H/I).
Cryostat sections (15 mm) were prepared after sacrifice at P27. Sections were stained for GFP (A,F), GST p (B,G) and GFAP (C,H) followed by DAPI
counterstain (D,I). Merged color overlays are presented in panels E and J. Cell types within the corpus callosum (WM) were counted as GFAP +, GSTp +,
GSTp weakly + and double negative (indeterminate). Panels A–E illustrate a representative GFAP+ cell, and panels F–J illustrate a GSTp+ cell. Panel K
depicts quantitativedata averagedfrom 3 IL hemispheres and6 CL hemispheres.* indicatesp,0.05 comparedto CLHas determined by student’s t-test.
Scale bar represents 20 mm.
doi:10.1371/journal.pone.0009567.g003
Neonatal Astroglial Dysgenesis
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astrocyte generation. No single factor alone significantly altered
GFAP expression (data not shown), although GFAP expression
was elevated in spheres treated with EGF in combination with LIF
and/or TGFß1 (Fig. 4A,B). The combination of EGF, LIF and
TGFß1 yielded the highest GFAP expression. The expression of
Zebrin II was not significantly affected by treatment with EGF,
LIF and TGFß1 either alone or in combinations. A significant
decrease in GS expression was observed in cells treated with EGF
in the presence of LIF, TGFß1 or a combination of both, as
compared to cells treated with EGF alone (Fig. 4A,B).
Specific Cytokine Combinations Differentially Regulate
Expression and Phosphorylation Status of Transcription
Factors
As combinations of cytokines were more effective than single
factors we hypothesized that they were synergistically activating
intracellular signaling pathways. We analyzed the status of STAT
and Smad transcription factors, which are known to be associated
with astrogliogenesis. When tested alone, EGF had little effect on
STAT and Smad phosphorylation. LIF increased the phosphor-
ylation of STAT-3 on both serine 727 and tyrosine 705, both in
the presence and absence of TGFß1 or EGF. While treatment
with neither LIF nor EGF affected pSmad2/3 levels, TGFß1
induced Smad 2/3 phosphorylation. This heightened pSmad2/3
level observed in TGFb-treated cells was unaffected by the
presence of either EGF, LIF or a combination of both LIF and
TGFb (Figure 5A,B). Phosphorylation of Smad1 was undetectable
under all conditions tested (Fig. 5A). The levels of total STAT3,
pSTAT3
Ser and pSTAT3
Tyr were elevated in the presence of LIF
(Fig. 5A). The elevated levels of pSTAT3
Ser were comparable in
cells treated with LIF either in the presence or absence of EGF or
TGFb or both. However, an approximately 9 fold increase in
pSTAT3
Tyr level was observed in cells treated with a combination
EGF, LIF and TGFb1, as compared to those treated with LIF
alone or with EGF or TGFb1 (Fig. 5A,C).
TGFß1 Synergizes with EGF to Induce Astrocyte
Proliferation and Antagonizing ALK5 Blocks This
Astrocyte Generation In Vitro
The changes we observed in the levels of astrocytic proteins
could occur either as a result of increased astrocyte numbers or
increased expression of astrocyte markers. To distinguish between
these two possibilities, we dissociated the gliospheres, stimulated
the single cells with cytokines and counted the percentage of
astrocytes by GFAP immunostaining. We found that no factor
alone increased the percentage of astrocytes. When these factors
were combined, LIF together with EGF significantly increased the
percentage of GFAP positive cells (Fig. 6A). However, it was the
combination of all three cytokines that most significantly increased
astrocyte numbers compared to controls (Fig. 6A).
In order to determine whether cell proliferation was responsible
for this increase in astrocytes, gliospheres were treated with EGF
in combination with LIF and TGFß1 followed by a short BrdU
pulse. We found that the combination of EGF with TGFß1
stimulated the incorporation of BrdU into the GFAP+ cell
population (Fig. 6B,C,D). Interestingly, LIF suppressed the
proliferative effects of EGF and TGFß1, by decreasing the
Table 1. Quantitative PCR analysis for genes associated with
astrogliogenesis following neonatal H/I.
Gene Fold Change at 7 days of recovery
EGFR 1.44
LIF 2.1
LIFR 1.1
gp130 1.5
TGFb14 . 1
ALK1 0.625
ALK5 1.8
Ipsilateral and contralateral SVZs were dissected at 7 d post H/I. Total RNA was
isolated and amplified by Q-PCR using Taqman primers specific for the genes
shown in the table, and normalized to the expression of 18S RNA. Values for all
transcripts except LIFR were significantly different from the CLH as determined
by the REST program.
doi:10.1371/journal.pone.0009567.t001
Figure 4. Combinations of EGF, LIF and TGFß1 effectively
increase astrocyte generation in gliosphere cells. Gliospheres
were grown in ProN supplemented with B104 conditioned medium and
10 ng/ml FGF-2. They were dissociated and plated onto culture dishes
for 6 h in differentiation media with 2% serum and then switched to
differentiation media supplemented with either 5 ng/mL EGF (E), LIF (L),
TGFß1 (T) or combinations for 48 h. (A) Densitometric analyses of
protein levels on Western Blots were performed for GFAP, Zebrin II and
GS as indices of astrocyte differentiation. (B) Values represent the mean
fold change over controls 6 SEM from 3 independent experiments.
* and # denote a significant increase and decrease respectively from
control (P,0.05).
doi:10.1371/journal.pone.0009567.g004
Neonatal Astroglial Dysgenesis
PLoS ONE | www.plosone.org 5 March 2010 | Volume 5 | Issue 3 | e9567Figure 5. Differential effect of EGF, LIF and TGFß1 on Smad 2/3 and STAT3 phosphorylation in gliospheres. Gliospheres were grown in
ProN supplemented with B104 conditioned medium and 10 ng/ml FGF-2. They were dissociated and plated onto culture dishes and then treated with
5 ng/mL EGF (E),LIF(L),TGFß1 (T)either aloneor combinations in differentiation mediafor 30 min.(A) Total cell lysates were collectedandWestern blot
analysis was performed to determine levels of total Smad2/3, STAT3, pSmad 2/3 on Ser465/467 and pSTAT3 on Ser727 and Tyr705 residues. (B) Values
represent fold change in pSmad2/3 over Smad2/3. (C) Values represent fold change in pSTAT3
Tyr705 over STAT3, 6 SEM from 3 independent
experiments. * Denote significant increase from control, # significant increase from treatment with a single cytokine or combination of two (P,0.05).
doi:10.1371/journal.pone.0009567.g005
Neonatal Astroglial Dysgenesis
PLoS ONE | www.plosone.org 6 March 2010 | Volume 5 | Issue 3 | e9567Figure 6. TGFß1 induced increased astrocyte proliferation is mediated through the ALK5 receptor. Gliospheres were plated onto
chamber slides in differentiation media supplemented with 5 ng/mL of EGF (E), LIF (L), and TGFß1 (T) in different combinations for 96 h and were
pulsed with BrdU for the last 3 h in culture. The percentage of (A) GFAP+ and (B) GFAP+/BrdU+ cells is depicted. (C,D) Representative images of
gliospheres differentiated in EGF (C) or combination of EGF and TGFß1 (D) stained for GFAP (green) and red (BrdU). (E,F) Gliospheres were similarly
treated with EGF or a combination of EGF and TGFß1 for 96 hrs and the effect of these cytokines on oligodendrocyte generation were determined by
O4 staining. Representative images of gliospheres differentiated in EGF (E) or combination of EGF and TGFß1 (F) stained for GFAP (green) and red (O4)
are shown. (G) Gliospheres were propagated in EGF or EGF+ TGFß1 in the presence or absence of 10 mM SB431542, a potent ALK5 inhibitor, pulsed
with BrdU and stained for GFAP and GFAP/BrdU (G). Results are representative of 3 independent experiments. * indicate statistically significant
differences (p,0.05) for each condition compared to medium alone (M) controls using Student’s t-test. The scale bar represents 35 mm for panels C,D
and 50 mm for panels E,F.
doi:10.1371/journal.pone.0009567.g006
Neonatal Astroglial Dysgenesis
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that specific cytokines altered the morphology of GFAP+ cells,
as gliosphere cells cultured in the presence of EGF produced
GFAP+ cells with broad, flattened processes whereas the addi-
tion of TGFß1 produced cells with highly stellate, thin pro-
cesses (Fig. 6C,D). While EGF and TGFb1 increased astrocyte
proliferation, growth in EGF either alone or in combination with
TGFb1 had no effect on oligodendrocyte progenitor production.
The number of O4 positive cells obtained in EGF alone or in
combination with TGFb1 was comparable (Fig. 6E, F).
As TGFß1 induced SVZ-derived gliospheres to produce more
astrocytes and the signal transduction studies indicated that
TGFß1 was stimulating the ALK5 receptor, we hypothesized that
inhibiting the ALK5 receptor would inhibit astrocyte generation.
Treatment with ALK5 antagonist SB431542 had no effect on
BrdU incorporation into gliosphere cells stimulated with EGF
alone. However, as expected SB431542 completely inhibited the
EGF and TGFb1–stimulated increase in proliferating astrocytes as
measured by BrdU incorporation (Fig. 6G).
Increased Astrogliosis after Hypoxia/Ischemia Is
Abrogated by ALK5 Inhibition In Vivo
Based on the findings above that inhibiting ALK5 diminished
astrocyte generation in vitro, we tested the hypothesis that
inhibiting ALK5 after neonatal H/I would similarly reduce
astrogliosis in vivo. At 4 days after H/I, astrogliosis in the injured
SVZ was observably higher (Fig. 7C,D) than in the contralateral
SVZ (Fig. 7A,B) as shown by intense GFAP expression. To
antagonize ALK5 in vivo, we administered SB505124 to animals
immediately after H/I, and twice daily for 4 days after injury and
analyzed GFAP intensity in each hemisphere at 4 days of recovery.
Unlike SB431542, this ALK5 kinase inhibitor crosses the blood
brain barrier [24,25]. Visually, there was a clear decrease in
staining for GFAP (Fig. 6E,F), and a quantitative analysis of
fluorescence intensity confirmed that SB505124 treatment signif-
icantly decreased GFAP expression in the damaged SVZ (Fig. 7G,
p,0.05). Although SB505124 prevented the increase in GFAP
staining within the SVZ, GFAP staining intensity in the un-injured
hemisphere was not different between vehicle-and SB505124
treated animals, and the injury-induced increase in GFAP was
indistinguishable in neocortex of vehicle and SB505124 treated
animals (Figure S2). Thus, administering an ALK5 antagonist in
vivo appears to abrogate the injury-induced astrocyte generation in
the SVZ. At this early time-point of recovery, we did not observe
any change in staining for the oligodendrocyte marker Rip within
the subcortical white matter or SVZ (Data not shown [26]).
Discussion
Neonatal white matter damage occurs during that interval of
human development when SVZ cells are predominantly produc-
ing oligodendrocytes. This injury occurs when the late OPCs are
most abundant [27,28,29] and studies show that these progenitors
are extremely vulnerable to glutamate, oxidative stress and FasL
[30,31,32,33,34,35,36]. Recent studies indicate that oligodendro-
cyte progenitors are present within abnormal white matter of
human PVL cases, but are unable to properly differentiate and to
replace damaged OPCs [37,38]. Back et al (2005) suggested that
certain factors made by reactive astrocytes, such as hyaluronan,
Figure 7. Increased astrogliosis at 4 days of recovery observed in the injured SVZ after H/I is decreased by ALK5 inhibition in vivo.
(A,B) Representative images of CL (A) and IL (B) hemispheres from age-matched control animals (twice daily i.p. SB505124 injections) and stained
with antibodies against GFAP (green) and counterstained with DAPI (blue). (C,D) Images of CL (C) and IL hemispheres (D) of H/I vehicle-treated
animals. (E,F) Representative images of CL (E) and IL (F) of SB505124-treated animal at 4 days after injury. (G) Densitometric analyses of GFAP
intensity within the SVZ in H/I and H/I + SB treated animals at 4 days after injury. Untouched controls treated with SB compound were also analyzed
and no significance was found between IL and CL hemisphere data (data not shown). * and ** denote p,0.05 using ANOVA analysis with Fisher’s
PLSD post-hoc test comparing vehicle to H/I and H/I to H/I + SB respectively. Scale bar represents 50 mm.
doi:10.1371/journal.pone.0009567.g007
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oligodendrocyte progenitors both in human multiple sclerosis
lesions and in animal models of experimental autoimmune
encephalitis (EAE) [39]. Thus reactive gliosis subsequent to
neonatal white matter injury may directly contribute to the failure
of myelin formation.
Our studies and others have established that there is an
expansion of the SVZ neural stem/progenitor cell population,
resulting in neuronal and some glial cell replacement
[7,9,10,11,13,40]. Therefore, this regenerative response should
lead to significant OPC replacement, especially since this injury is
occurring precisely when the majority of OPCs are being
generated. However, OPC replacement in both rat models and
in human infants is limited. We hypothesized that the signals that
determine sequential cell fate specification within the SVZ are
disturbed following H/I adversely affecting gliogenesis in the
developing brain. In the studies reported here we analyzed (1)
whether there is aberrant generation of oligodendrocytes and
astrocytes from SVZ progenitors subsequent to neonatal H/I; (2)
whether there is increased expression of extrinsic signals that
promote astrocyte differentiation in the SVZ following H/I; (3)
whether those signals that are aberrantly expressed promote
astrocyte differentiation from glial restricted progenitors and (4)
whether inhibiting one of those signals would prevent aberrant
astrogliogenesis.
We observed increased astrogliosis in the injured hemisphere at
4 and 7 days of recovery. This end result could have occurred
though 3 possible routes: 1) OPC death, 2) astrocyte proliferation
or 3) aberrant differentiation of SVZ glial progenitors into
astrocytes. Were only scenario 1 occurring, then one would
predict that the regenerative expansion of SVZ precursors would
replace the depleted oligodendrocyte progenitors, which is
incomplete at best. Scenario 2 is surely occurring as numerous
studies have shown local astrocyte proliferation after H/I,
however; to our knowledge none attribute this astrogliosis to
aberrant production of astrocytes from the glioblasts in the SVZ
[41,42,43,44,45,46,47,48,49]. Using retrovirus fate mapping
techniques and immunohistochemistry for lineage-specific mark-
ers, we provide data that strongly support the third scenario - that
SVZ glial progenitors are aberrantly differentiating after injury.
Importantly, we show that some of the new astrocytes that are
produced are derived from SVZ cells as opposed to locally
proliferating immature astrocytes confirming our hypothesis that
gliosis in the immature brain may be qualitatively different from
gliosis in the adult brain. In this manuscript, we propose an
alternative mechanism for the generation of ‘‘excess’’ astrocytes in
the injured brain–altered generation of astrocytes from subven-
tricular zone progenitors. This alternative source may be further
amplified by astrocyte proliferation locally.
Interestingly, we also observed an increase in the percentage of
weakly stained GSTp+ cells and indeterminate cell types in the
injured white matter, which is reminiscent of the halt in the
differentiation of OPCs as recently observed in human PVL cases
[37,38]. Our SuperArray results indicate an up-regulation of
CD44 in the injured SVZ, the cell surface glycoprotein capable of
binding hyaluronic acid, supporting a potential role for hylaur-
onan as an inhibitor of oligodendrocyte production after injury.
Additionally, we found that there were significantly fewer labeled
cells in the injured hemisphere as compared to the contralateral
and control hemispheres. As we have previously demonstrated that
there is a depletion of progenitors acutely after neonatal H/I
[50,51,52] the depletion of these progenitors could reduce the
proportion of cells available for retroviral infection. To test this
hypothesis, we examined the extent of retrovirus infection 2 days
after injury and observed far fewer infected cells in the damaged
SVZ and in the corpus callosum 48 h after infection. Thus, the
expansion of the stem/progenitor cells in the SVZ that we have
previously documented may not be sufficient to replenish damaged
white matter oligodendrocytes progenitors. However, we cannot
rule out the possibility that SVZ cells that divided after the injury
may fail to survive and that the reduced number of retrovirally
labeled cells is a consequence of persistent glial progenitor cell
death.
Cumulatively, our results demonstrate that there is a shift in the
cell types generated from the SVZ, and that the cells that are
produced from the SVZ after injury preferentially become
astrocytes rather than oligodendrocytes. It is well established that
radial glial cells are an important source of astrocytes in the
developing brain [53] and recently, Sizonenko et al. 2008
documented accelerated transformation of radial glia into
astrocytes as a mechanism for astrogliogenesis after neonatal H/
I [54]. Our studies provide an additional mechanism whereby
astrocyte generation is enhanced from a different set of precursors,
those within the SVZ. It is known that axonal loss will lead
oligodendrocyte precursor death [55]. Although axonal loss occurs
following neonatal H/I, we have previously shown that this loss is
disproportional to decreased oligodendrocyte generation [56].
Therefore, axonal loss is not sufficient to explain the loss of
oligodendrocytes, but it may contribute to the decrease in
oligodendrocyte replenishment after injury,
We provide evidence both from in vivo analyses as well
as from in vitro studies that indicate that elevated levels of
cytokines post injury are stimulating astrocyte proliferation.
Extrinsic cytokines and growth factors provide decisive signals
that govern the differentiation choices of neural precursors
[57]. These extracellular signaling molecules work though
intracellular signaling cascades to either activate or repress distinct
groups of transcription factors. Gene array analysis validated by
QRT-PCR revealed an increase in the expression of LIF and
TGFß1 as well as their corresponding receptors, LIFR, gp130 and
AK5 in the SVZ at 7 days recovery from H/I. We have also found
that EGFR is more highly expressed on putative neural stem cells
and SVZ progenitors after H/I [23]. These factors have been
previously shown to promote astrocyte differentiation from
embryonic and fetal neural precursors [58,59,60,61,62,63,64,65].
As reported here, as well as in a recently published study, we found
that there was no change in the expression of EGF in the SVZ
after neonatal H/I. This result appears to contradict the
importance of EGFR signaling for the astrogliogenesis observed,
however, TGFa, not EGF, is the major EGF-R ligand during
CNS development where TGFa is expressed 15 to 150 times
higher than EGF [66].
To date, the effects of EGF, LIF and TGFß1 have not been fully
assessed on SVZ glial progenitors. We found that the combination
of EGF with either LIF or TGFß1 increased astrocyte generation
from gliospheres, an in vitro model for studying SVZ glial
progenitors. GFAP expression increased with combinations of
these growth factors, and the combination of all 3 was most
effective in promoting astrocytic protein expression. Despite
increased GFAP expression, astrocyte maturation, as measured
by the metabolic marker GS, was considerably reduced in all
cultures containing TGFß1. Of relevance to neonatal hypoxia/
ischemia, our findings support previous studies showing that
TGFß1 impairs astrocyte GS activity [67]. A consequence of
reduced GS expression is that the capacity of these astrocytes to
detoxify glutamate will be impaired. Without the capacity to
eliminate glutamate, OPCs and other cell types will be rendered
even more vulnerable to damage and eventual cell death.
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liferation [68,69], it has been shown to increase the proliferation of
glioblastoma [70]. As we show here for SVZ glial precursors, these
differences in the effects of TGFß1 could be due to varied
responsiveness of cells at different stages of differentiation.
Previous studies have suggested that proper myelination after
CNS injury requires astrocyte participation [71]. Our in vivo
studies show that astrocytes are being generated from the SVZ
after injury, suggesting that these SVZ-derived astrocytes may be
proliferating but not maturing properly to actively participate in
normal myelination. We found that EGF and TGFß1 were most
effective in increasing astrocyte proliferation. These findings
indicate that combinations of growth factors promote the
proliferation of SVZ-derived immature astrocytes, while retarding
their differentiation and that TGFß1 is a key stimulus.
Bone morphogenetic proteins of the TGFß family and LIF have
been shown to synergistically induce astrocyte differentiation from
fetal neuroepithelial precursors though a complex comprised of the
transcription factors Smad1 (via ALK1) and STAT3 respectively,
together with the transcriptional co-activator p300 [72]. Analo-
gously, we found that EGF, LIF and TGFß1 promoted astrocyte
differentiation from postnatal SVZ glial progenitors and that they
synergistically stimulated STAT-3 phosphorylation. These in vitro
experiments confirm results from an earlier study that showed
increased STAT-3 phosphorylation in the injured SVZ after H/I
[73]. We hypothesized that TGFß1 would act though ALK1 to
induce astrocyte specification; however, TGFß1 only increased
Smad 2/3 phosphorylation, reflecting signaling though ALK5
instead of ALK1. This result was not necessarily predictable since
ALK1 is activated by BMPs, and has been previously implicated in
astrocyte development. Supporting the importance of the ALK5
receptor, pharmacologically inhibiting ALK5 signaling with the
potent inhibitor SB431542 [74,75] prevented TGFb1-induced
immature astrocyte proliferation.
As our in vitro data suggested that TGFb1 signaling via ALK5
was central to the injury induced astrocyte generation from SVZ
glial progenitors, we asked whether antagonizing this receptor in
vivo would decrease the extent of astrogliosis after neonatal H/I.
To test this hypothesis in vivo, we used a hydrophilic ALK5
antagonist, SB505124 to inhibit ALK5 signaling. Studies have
shown that astrocyte proliferation increases around 3–4 days of
recovery [76], therefore we used this short recovery time point for
studying astrogliosis within the SVZ. At 4 days of recovery from
H/I we observed a significant increase in the GFAP staining
intensity in the ILH SVZ vs. the CLH SVZ. This increase was
significantly decreased when SB505124 was administered. Where-
as the most parsimonious explanation for this result is that
inhibiting ALK-5 antagonized the aberrant production of
astrocytes we cannot exclude the alternative explanation that this
antagonist delayed the maturation of newly generated astrocytes
but did not prevent their formation. However, the injury-induced
increase in GFAP expression in the neocortex appeared to be
unaffected by ALK-5 inhibition. These results suggest that the
decrease in GFAP expression in the SVZ is not simply due to
suppression of GFAP expression. In characterizing the conse-
quences of ALK-5 inhibition, it will be of interest to determine
whether astrogliogenesis is indeed inhibited by employing markers
of immature astrocytes such as vimentin or Zebrin II. These data
suggest that inhibiting TGFß1-signaling through the ALK5
receptor in the early stages of cell fate determination could create
an environment in the injured brain that would enable
regeneration to occur more robustly. It is quite likely that by
dampening the astrogliosis after injury, ALK5 inhibition may
promote oligodendrogliogenesis. However, our objective for this
experiment was to examine the astrocyte response after SB505124
administration. An analysis of oligodendrogliogenesis will require
evaluation at a later time point after injury because the precursors
must proliferate after the injury and also differentiate into fully
mature oligodendrocytes. Future studies will be needed to study
the long-term effects of antagonizing ALK5 signaling in the SVZ
towards restoring oligodendrocyte progenitor cell production after
injury.
Neonatal H/I is detrimental to the developing brain due to both
its pathological effects on oligodendrocyte progenitors and
neurons, but it also adversely affects white matter astrocyte
development as evidenced by these studies. We hypothesized that
altered cytokine signaling would affect the specification and
proliferation of astrocytic precursors and immature astrocytes
which would contribute to the imbalanced production of glial cells
from the neonatal SVZ after brain injury. The data provided in
this report fully substantiate the validity of this hypothesis. As the
neonatal brain is conducive for oligodendrocyte generation, our
studies suggest that a new focus of neonatal research should be on
evaluating whether antagonizing those signaling pathways that
induce astrocyte differentiation might restore normal oligoden-
drogliogenesis. The knowledge obtained from these studies may
well lead to interventions that can be applied to infants after an
ischemic injury or other disturbances of brain development to
enable the infant brain to develop more normally, thus decreasing
the incidence and lifelong neurological and psychiatric handicaps
that are too often sustained.
Methods
Ethics Statement
All research involving animals was conducted according to
relevant national and international guidelines. The animal
protocol for the work described in this report was approved by
the New Jersey Medical School IACUC, protocol #06069, and
these studies were in accordance with the National Institute of
Health Guide for the Care and Use of Laboratory Animals (NIH
Publications No. 80-23) revised in 1996. We further attest that all
efforts were made to minimize the number of animals used and
efforts were made to ensure minimal suffering.
Neonatal Hypoxia/Ischemia
Experiments were performed in accordance with research
guidelines set forth by the New Jersey Medical School and the
Society for Neuroscience Policy on the use of animals in
neuroscience research. Cerebral H/I was induced in P6 rats
(day of birth being P0), by a permanent unilateral (right) common
carotid artery cauterization under isoflurane anesthesia followed
by systemic hypoxia [2,4,77]. The neck wound was sutured with
surgical silk and the animals were returned to the dam to recover
for 1.5 h. Animals were then pre-warmed in jars for 20 min in a
37uC water bath. The pups were exposed to a humidified, hypoxic
atmosphere (8% O2/92% N2)a t3 7 uC for 75 min, allowed to
recover in room air, and then returned to their dams. Control
animals underwent the same procedure as experimental animals
but the carotid artery was not cauterized. In experiments where an
antagonist to the TGFb1 receptor was administered, animals were
treated twice daily, beginning immediately after H/I, with 5 mg/
kg SB505124 or vehicle alone via intraperitoneal injection.
Animals were deeply anesthetized with ketamine (75 mg/kg)/
xylazine (5 mg/kg), perfused with RPMI culture medium
containing 6 U/ml heparin followed by 4% paraformaldehyde,
pH 7.4. Brains were removed, cryoprotected, embedded in OCT,
frozen and sectioned for further analysis.
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SVZs from untouched control, contralateral and ILHs of H/I
animals at 7 days post recovery were microdissected and snap
frozen at 280uC. RNA was isolated using TRIZOL (Molecular
Research Center, Inc., Cincinnati, OH). cDNA probes were
prepared, labeled and hybridized to nylon Superarray stem cell
array as previously described, normalizing values to GAPDH [7].
Q-PCR was performed as described earlier [73].
Gliosphere Cultures
P4 rat pups were decapitated under sterile conditions and the
brains were placed into PBS with 0.6% glucose and 2 mM MgCl2.
Incisions were made ,2 mm from the anterior end of the brain
and ,3 mm posterior to the first cut. Blocks were transferred to
fresh PBS-glucose-MgCl2 and the region including the dorsolateral
SVZ (SVZDL) was microsurgically isolated, mechanically minced
and enzymatically dissociated using a 1:4 dilution of Accutase
(Innovative Cell Technologies, CA) at 37uC for 10 min. Glio-
spheres were cultivated by plating the cells at 1.5610
5 cells/mL in
ProN media (Dulbecco’s modified eagle’s medium/F12 media
containing 10 ng/ml d-biotin, 25 mg/ml insulin, 20 nM proges-
terone, 100 mM putrescine, 5 ng/ml selenium, 50 mg/ml apo-
transferrin, 50 mg/ml gentamycin) supplemented with 30% B104
conditioned medium [78]. Spheres generated after 7–10 days in
culture were dissociated in Accutase and used for experimentation.
Differentiated cells were obtained by culturing the cells with/
without cytokines in N2B2 media [ProN supplemented with
0.66 mg/mL BSA and 0.5% fetal bovine serum] for 72 h.
SB431542 was purchased from Tocris Cookson Inc. (Ellisville,
MO).
Western Blot Analysis
Gliospheres were dissociated with 1:4 diluted Accutase and
plated onto PdL-coated 60 mm plates in differentiation media
supplemented with 2% serum. After 6 h the cells were treated with
5 ng/ml of cytokines in differentiation medium. After 48 h
proteins were extracted and Western blot analysis was performed
for GFAP (Dako, Carpinteria, CA), aldolase C/Zebrin (gift from
Dr. Richard Hawkes), and GS (Chemicon, Temecula, CA). Total
STAT3, pSTAT3 tyrosine705 and pSTAT3 serine727, total
Smad2/3 and phosphorylated Smad1 and Smad 2/3 were
analyzed at 30 minutes of stimulation using antibodies from Cell
Signaling Technologies (Danvers, MA). The blots were stripped
and reprobed with anti-b-tubulin to determine equivalent loading
as described previously [79].
Immunocytochemistry
Cells were fixed briefly with cold acetone and then incubated in
rabbit anti-GFAP (1/500, Dako), rinsed well and then incubated
for 2 h with fluorochome conjugated secondary antibodies (1/200,
Jackson Immunoresearch). BrdU immunofluorescence was per-
formed as previously described [80]. Cells were visualized using an
Olympus AX70 microscope and imaged using a Photometrics
cooled charged coupled device camera (Tucson, AZ) interfaced
with IP Lab scientific imaging software (Scanalytics Fairfax, VA).
At least 6 random (nonadjacent) fields were counted per well
under a 406 objective and a total of 2 wells analyzed per 3
independent experiments. For the SB505124 experiment, images
were taken at 206magnification on 2 nonadjacent sections from
at least 4 animals per group.
Tissue sections (12 mm) were collected and immunohistochem-
istry was performed. For BrdU labeling experiments, BrdU
(Sigma, at 50 mg/kg body weight, 10 mg/ml in 0.007 N NaOH
in 0.9% NaCl) was administered intraperitoneally (i.p.) 2 days
following H/I. On day 7, animals were sacrificed by intracardiac
perfusion, cryoprotected, frozen and tissue sections encompassing
the region of brain subserved by the middle cerebral artery were
cut at 12 mm and mounted onto glass slides. Select tissue sections
were incubated for 1 h at RT in 2 N HCl, extensively rinsed with
borate buffer (pH 8.5), and blocked in a solution containing 10%
BSA, 10% goat serum in Tris buffer for 1 h. The sections were
then incubated with a rat monoclonal anti-BrdU (Accurate
Chemical, NY; 1:30) and mouse IgG anti-vimentin (V9 clone,
Roche, 1:100) overnight at 4uC. Sections were further incubated
in fluorochrome-conjugated secondary antibodies (Jackson Labo-
ratories, PA; 1:200) for 2 h at room temperature. DAPI was used
to stain all nuclei. Other sections were stained using the Rip
antibody (supernatant 1:4) and anti-GFAP (rabbit anti-GFAP
1:500) using the same protocol as above but omitting the HCl
incubation and borate buffer rinses. Images from corresponding
brain regions in ipsilateral and CLHs were captured at a
standardized exposure time. IP Lab was used to measure the
density of staining fluorescence. The average density was
calculated for control, H/I and H/I plus SB505124 treatment.
Retrovirus Production
Replication-deficient viruses with vsv-g coats were generated
from pNIT-GFP plasmid [81,82]. pNIT-293 cells were main-
tained for at least two weeks prior in 0.8 mg/ml G418 in DMEM
with 10% newborn calf serum. 2–3 days before transfection, cells
were split onto 7 PDL-coated plates in media lacking G418.
Transfection was performed when the pNIT-293 cells were 90–
95% confluent. On the transfection day, vsv-g mixture was
prepared with 27 mg plasmid/100 mm plate, to make a total of
0.5 ml/plate. A separate tube was prepared with a 1:25 dilution of
Lipofectamine
TM 2000 Reagent (Invitrogen, Carlsbad, CA).
Tubes were mixed separately, and then mixed together followed
by incubation at room temperature for 30 min. The media was
removed and ,4 mL of transfection media was added to each
plate. Plates were incubated for 4 h, and checked every 20 min. to
redistribute media over entire plate. At the end of 4 h, transfection
media was aspirated and replaced by slowly adding 10 mL of
media (without G418). Two to 3 days after transfection, the
supernatant was collected on ice and filtered though a 0.45 mm
cellulose filter. Conical tubes containing viral supernatant were
centrifuged at 19,200 rpm in Surespin 630 rotor for 2.5 h in
Sorvall ultracentrifuge at 4uC. Supernatant was aspirated and
pellet diluted 1/200 in cold sterile HBSS. The tube was left on ice
for 2 h, or until the pellet was completely dissolved. Viral titers
were determined in CFU by incubating NIH3T3 cells with serial
dilutions of retrovirus. At 48 h post infection the number of GFP+
cell clusters were counted. The CFU was calculated by multiplying
the number of GFP+ cell clusters by the dilution factor. DAP
retrovirus was produced and titered as described previously [83].
Retroviral Fate Mapping
Two days after H/I (P8) 2–5 mL of DAP or pNIT replication
deficient retroviruses with 8 ug/mL polybrene were stereotacti-
cally injected at a rate of 0.2 ml/min targeting the lateral ventricles
of anesthetized rat pups at the following coordinates: A 1.0 mm, L
1.2 mm, D 2.5 mm. At 2, 10 or 19 days after injection animals
were anesthetized with ketamine (75 mg/kg)/xylazine (5 mg/kg),
perfused with RPMI culture medium containing 6 U/ml heparin
followed by 4% paraformaldehyde, pH 7.4. Brains were removed,
cryoprotected, frozen in OCT and sectioned for further analysis.
Twenty mm sections were incubated in TBS/0.3% Triton-X-100
for 30 min, blocked for 1 h, and incubated overnight with primary
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Tigard, Oregon). Sections were washed extensively with TBS/
0.05% Triton-X-100 and incubated for 4 h at RT with
fluorochome-conjugated secondary antibodies (Jackson Immunor-
esearch). After extensive rinses, the sections were counterstained
with DAPI and coverslipped with gelmount. For experiments
using the DAP retrovirus, staining was performed at 10 days after
injection as described previously [10] on 40 mm free floating
sections and cell types were characterized morphologically as
astrocytes, oligodendrocytes or indeterminate. To analyze pheno-
typic markers, animals were perfused 19 days after pNIT injection.
Twelve mm sections were incubated in TBS/0.3% Triton-X-100
for 30 min, blocked for 1 h, and incubated overnight with primary
antibodies against GSTp (rabbit anti-GSTp, 1:500, MBL, Santa
Cruz, CA), GFAP (mouse anti-GFAP 1:500, Cell Signaling) and
GFP (chicken anti-GFP, 1:2,500, Aves). Sections were washed
extensively with TBS/0.05% Triton-X-100 and incubated for 4 h
at RT with fluorochome-conjugated secondary antibodies (Jackson
Immunoresearch). After extensive rinses, the sections were
counterstained with DAPI and coverslipped with gelmount. For
quantitative analysis, at least 6 nonadjacent sections for each
group were analyzed. Images of pNIT-infected cells with
immunofluorescence were taken under 636 oil magnification.
All animal work was performed according to Institutional Animal
Care and Use Committee (IACUC) guidelines of UMDNJ,
approved protocol #0609.
Statistical Analyses
Results from cell culture experiments were analyzed for
statistical significance by ANOVA with Fisher’s PLSD post-hoc
analysis or using a Student’s t test. Error bars represent SEMs
unless noted otherwise. Comparisons were interpreted as signif-
icant when associated with p,0.05. The REST algorithm was
used to evaluate the qPCR data [84].
Supporting Information
Figure S1 Fewer SVZ cells are infected by replication deficient
retroviruses in the injured hemisphere. (A) Number of retrovirally-
labeled cells counted in the hypoxic sham, contralateral and ILHs
at 9 days of recovery with DAP virus. (B) Distribution of labeled
cells among various brain regions. For short-term analysis of
retrovirus infection, 5 ul of pNIT was injected at P8 as described
above and animals sacrificed 48 h later. Cryostat sections were
prepared and stained for GFP. (C,D) Representative panels of
pNIT-labeled cells in contralateral (C) and ipsilateral SVZs (D)
48 h after bilateral intraventricular retrovirus injection.
Found at: doi:10.1371/journal.pone.0009567.s001 (0.08 MB TIF)
Figure S2 Neocortical Astrogliosis is not blocked as a conse-
quence of antagonizing ALK-5. Representative images of CL and
IL hemispheres from H/I animals that received vehicle or twice
daily i.p. SB505124 injections for 4 days and then killed and
processed for immunofluorescence. Sections were stained with
antibodies against GFAP. Scale bar represents 50 mm.
Found at: doi:10.1371/journal.pone.0009567.s002 (7.73 MB TIF)
Table S1 Results from the SuperArray stem cell array. mRNAs
pooled from at least 6 animals at 7 days of recovery were labeled
and hybridized to the Nylon membrane. Fold differences in
ipsilateral vs. contralateral are indicated. Values are averages from
3 experiments with 3 independent sets of mRNAs.
Found at: doi:10.1371/journal.pone.0009567.s003 (0.04 MB
RTF)
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